Unique ID issued by UMIN | UMIN000049695 |
---|---|
Receipt number | R000056604 |
Scientific Title | Effect of use of test product on vaginal microbiota - Open label test - |
Date of disclosure of the study information | 2022/12/19 |
Last modified on | 2024/06/18 15:36:49 |
Effect of use of test product on vaginal microbiota
Effect of use of test product on vaginal microbiota
Effect of use of test product on vaginal microbiota
- Open label test -
Effect of use of test product on vaginal microbiota
- Open label test -
Japan |
Healthy subjects
Adult |
Others
NO
Evaluate the effect of test product use on vaginal microbiota
Efficacy
vaginal microbiota
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Device,equipment |
Use test product for 3 days
20 | years-old | <= |
46 | years-old | > |
Female
(1) Subjects of men and women aged 20 to 40
(2) Subjects whose menstrual cycle is around 28 days
(3)Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing
(1) Subjects with a history of diabetes, liver disease, renal disease, gastrointestinal disease, heart disease, respiratory disease, peripheral vascular disease, or other serious disease
(2) Subjects with diseases currently being treated
(3) Subjects with a history of gynecological disease (endometriosis, uterine fibroids, ovarian cysts, cervical cancer, uterine cancer, etc.)
(4) Subjects with food and drug allergies
(5) Female subjects who wish to become pregnant while participating in this study, female subjects who are pregnant (including those who may be pregnant) or who are breastfeeding
(6) Subjects using products or drugs that affect hormone balance
(7) Subjects receiving antibiotics
(8) Subjects who participate in strenuous sports and who are on a diet
(9)Subjects with irregular lifestyle
(10) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period
(11) Subjects who are continuously receiving medical treatment (including OTC and prescription drugs)
(12) Subjects who consume alcohol excessively
(13) Subjects who cannot abstain from alcohol from the day before the test to the day of the test
(14) Subjects participating in or planning to participate in other clinical trials at the start of this study
(15) Subjects who are otherwise judged by the principal investigator or subinvestigator to be unsuitable for the study
25
1st name | Naoki |
Middle name | |
Last name | Miura |
Miura Clinic, Medical Corporation Kanonkai
Internal medicine
530-0044
Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-6135-5200
info@miura-cl.jp
1st name | Makoto |
Middle name | |
Last name | Terashima |
Oneness Support Co., Ltd.
Clinical Trial Division
530-0044
Higashitenma building 4F, 1-7-17, Higashitenma, Kita-ku, Osaka,
0648018917
mterashima@oneness-sup.co.jp
Miura Clinic, Medical Corporation Kanonkai
GRAPHICO, Inc.
Profit organization
Miura Clinic, Medical Corporation Kanonkai IRB
Higashitenma building 4F, 1-7-17, Higashitenma, Kita-ku, Osaka
0648018917
mterashima@oneness-sup.co.jp
NO
医療法人花音会みうらクリニック(大阪府) Miura Clinic, Medical Corporation Kanonkai(Osaka)
2022 | Year | 12 | Month | 19 | Day |
Unpublished
Completed
2022 | Year | 10 | Month | 17 | Day |
2022 | Year | 10 | Month | 20 | Day |
2022 | Year | 12 | Month | 19 | Day |
2023 | Year | 03 | Month | 31 | Day |
2022 | Year | 12 | Month | 05 | Day |
2024 | Year | 06 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056604